MikeKato2002
3 years ago
Correct! I rode this one back in 2016 betting that some day they would get FDA approval for a marketable product. Now we have that marketable product and a good chunk of money to fund the pipeline for the next product. Meanwhile the stock trades at a historically deep discount to where it was without FDA approval.
I'm back in at $14.50 for the first time since 2016. Free money.
Good Luck!
04/20/2016 08:26:57 Bought 1200 CARA @ 8.98
-10,785.95 9.95 0.00
04/20/2016 08:26:57 Bought 300 CARA @ 8.97
-2,691.00 0.00 0.00
04/20/2016 09:51:48 Bought 500 CARA @ 8.51
-4,264.95 9.95 0.00
04/29/2016 12:04:51 Bought 1000 CARA @ 6.05
-6,059.95 9.95 0.00
11/16/2016 18:23:35 Sold 2500 CARA @ 12.24
30,589.38 9.95 0.67
11/18/2016 20:22:06 Sold 500 CARA @ 12.0202
6,000.02 9.95 0.13
MikeKato2002
3 years ago
Item 8.01 Other Information.
As previously disclosed, on August 23, 2021, Cara Therapeutics, Inc. (โCaraโ) received approval of its New Drug Application for KORSUVAโข injection for the treatment of moderate-to-severe pruritus in hemodialysis patients from the U.S. Food and Drug Administration (the โApproval Milestoneโ). Pursuant to a securities purchase agreement (the โPurchase Agreementโ) between Cara and Vifor (International) Ltd. (โVifor Pharmaโ), dated October 15, 2020, Cara is eligible to receive $50 million common stock investment at a 20% premium to the 30-day trailing average price of Caraโs common stock ending on the date immediately prior to the achievement of the Approval Milestone. A description of the Purchase Agreement is included in Caraโs Current Report on Form 8-K filed with the Securities and Exchange Commission (โSECโ) on October 20, 2020 and is incorporated herein by reference.
In connection with the achievement of the Approval Milestone on August 23, 2021, Cara will receive from Vifor Pharma a $50.0 million investment in Caraโs common stock at a price of $15.23 per share, equaling 3,282,391 shares of Caraโs common stock (the โMilestone Investmentโ). The closing of the Milestone Investment will occur within five business days following the expiration of the requisite waiting period under the Hart-Scott-Rodino Antitrust Improvement Act of 1976.
This Current Report on Form 8-K is not an offer to sell or the solicitation of an offer to buy shares of shares of common stock or other securities of Cara.
http://archive.fast-edgar.com/20210831/ABBO422D8C22N2Z2222H2CZZBCASZ2U2D232/tm2126615d1_8k.htm
TheFinalCD
3 years ago
sold most around even after adding lower
still have 2500 shares left
#LETS SEE
Sell 4,000 Shares Limit $15.21 Expires on 10/25/2021 12:43 PM 08/24/2021
Sold 2,950 $15.21 Settles 08/26/2021 12:43 PM 08/24/2021
Sold 1,050 $15.21 Settles 08/26/2021 12:43 PM 08/24/2021
CLOSEDFilledCost Basis Method*: View/Edit Order #: 55147402
Sell 4,000 Shares Limit or Better $15.22 Expires on 10/25/2021 12:44 PM 08/24/2021
Sold 500 $15.235 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 500 $15.235 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 300 $15.235 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 200 $15.232 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 1,000 $15.235 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 100 $15.23 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 669 $15.2301 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 100 $15.2301 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 100 $15.2301 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 200 $15.231 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 100 $15.2301 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 100 $15.2301 Settles 08/26/2021 12:44 PM 08/24/2021
Sold 131 $15.2301 Settles 08/26/2021 12:44 PM 08/24/202